Christopher Geisert
Senior Associate Scientist - LNP Formulations Stylus Medicine
Christopher (Chris) Geisert is an Associate Scientist at Stylus Medicine, where he focuses on optimizing lipid nanoparticle (LNP) composition, formulation, and scale up to advance in vivo genetic medicine. He is excited by the potential of in vivo gene therapy to transform patient care, particularly through the next generation of CAR T and T cell–based therapies.
Chris’ work spans LNP design through process development, with a particular interest in how formulation parameters influence extra hepatic delivery performance. In addition to his laboratory role, he serves as Stylus’s Benchling administrator, supporting efficient data capture, streamlined experiment workflows, and cross team collaboration.
Outside the lab, Chris enjoys biking around the Boston area and writing and playing music.
Seminars
- Overview of Stylus’ in vivo gene editing system and therapeutic potential
- Key insights on optimizing process conditions to enhance mRNA and DNA LNP formulation quality and consistency
- Advances in lipid formulation design that improve extrahepatic biodistribution and drive efficient T-cell delivery in vivo
